XWELL Announces Closing of $1.4 Million Registered Direct Offering Priced At Premium to Market
XWELL, Inc. (Nasdaq: XWEL) has successfully closed its previously announced registered direct offering, raising approximately $1.4 million in gross proceeds. The company issued and sold 652,705 shares of common stock at a purchase price of $2.18 per share, which was priced at a premium to market. XWELL intends to use the net proceeds for working capital and general corporate purposes.
The offering was conducted under a shelf registration statement on Form S-3 that was filed with the SEC on August 4, 2023, and declared effective on September 29, 2023. A final prospectus supplement and accompanying base prospectus have been filed with the SEC and are available on their website.
XWELL, Inc. (Nasdaq: XWEL) ha chiuso con successo l'offerta diretta registrata precedentemente annunciata, raccogliendo circa 1,4 milioni di dollari di proventi lordi. L'azienda ha emesso e venduto 652.705 azioni di azioni ordinarie a un prezzo di acquisto di 2,18 dollari per azione, che è stato fissato a un premio rispetto al mercato. XWELL intende utilizzare i proventi netti per capitale circolante e scopi aziendali generali.
L'offerta è stata condotta sotto una dichiarazione di registrazione a scaffale in base al modulo S-3, presentata alla SEC il 4 agosto 2023, dichiarata efficace il 29 settembre 2023. Un supplemento al prospetto finale e il prospetto base accompagnatori sono stati presentati alla SEC e sono disponibili sul loro sito web.
XWELL, Inc. (Nasdaq: XWEL) ha cerrado con éxito su oferta directa registrada previamente anunciada, recaudando aproximadamente 1.4 millones de dólares en ingresos brutos. La empresa emitió y vendió 652,705 acciones de acciones comunes a un precio de compra de 2.18 dólares por acción, que se fijó a una prima sobre el mercado. XWELL tiene la intención de utilizar los ingresos netos para capital de trabajo y fines corporativos generales.
La oferta se realizó bajo una declaración de registro de estantería en el Formulario S-3 que se presentó a la SEC el 4 de agosto de 2023, y se declaró efectiva el 29 de septiembre de 2023. Un suplemento del prospecto final y el prospecto base correspondiente han sido presentados a la SEC y están disponibles en su sitio web.
XWELL, Inc. (Nasdaq: XWEL)는 이전에 발표한 등록 직접 발행을 성공적으로 종료하였으며, 총 140만 달러의 수익을 올렸습니다. 회사는 652,705주의 보통 주식을 주당 2.18달러에 발행 및 판매하였으며, 이는 시장가보다 프리미엄을 붙인 가격입니다. XWELL은 순수익을 운영 자본 및 일반 기업 목적에 사용할 계획입니다.
이번 발행은 2023년 8월 4일 SEC에 제출된 S-3 양식의 선반 등록 성명서에 따라 진행되었으며, 2023년 9월 29일에 효력을 발휘하였습니다. 최종 투자설명서 보충서와 기본 투자설명서는 SEC에 제출되었으며, 해당 웹사이트에서 확인할 수 있습니다.
XWELL, Inc. (Nasdaq: XWEL) a réussi à clôturer son offre directe enregistrée précédemment annoncée, levant environ 1,4 million de dollars de produits bruts. La société a émis et vendu 652 705 actions d'actions ordinaires à un prix d'achat de 2,18 dollars par action, ce qui a été fixé à un prix supérieur au marché. XWELL envisage d'utiliser les produits nets pour le fonds de roulement et des fins d'entreprise générales.
L'offre a été réalisée dans le cadre d'une déclaration d'enregistrement en étagère sur le formulaire S-3 qui a été déposée auprès de la SEC le 4 août 2023 et déclarée effective le 29 septembre 2023. Un supplément de prospectus final et le prospectus de base associé ont été déposés auprès de la SEC et sont disponibles sur leur site Web.
XWELL, Inc. (Nasdaq: XWEL) hat erfolgreich das zuvor angekündigte registrierte Direktangebot abgeschlossen und dabei etwa 1,4 Millionen Dollar an Bruttoerlösen erzielt. Das Unternehmen hat 652.705 Aktien zum Kaufpreis von 2,18 Dollar pro Aktie ausgegeben und verkauft, was über dem Marktpreis lag. XWELL beabsichtigt, die Nettomittel für Betriebs- und allgemeine Unternehmenszwecke zu verwenden.
Das Angebot wurde unter einer Registernotiz gemäß Formular S-3 durchgeführt, die am 4. August 2023 bei der SEC eingereicht und am 29. September 2023 für wirksam erklärt wurde. Ein endgültiger Prospektzusatz sowie der zugrunde liegende Prospekt wurden bei der SEC eingereicht und sind auf deren Website verfügbar.
- Successful closing of $1.4 million registered direct offering
- Offering priced at a premium to market at $2.18 per share
- Funds to be used for working capital and general corporate purposes
- Potential dilution of existing shareholders' ownership
Insights
XWELL's
- Positive: Minimal dilution for existing shareholders
- Negative: funds raised, potentially insufficient for significant growth initiatives
The use of proceeds for working capital and general corporate purposes is vague, leaving investors to speculate on the specific allocation. This lack of clarity may impact investor confidence in the company's strategic direction and financial management.
XWELL's positioning as an "authority in wellness solutions for people on the go" aligns with growing trends in health and convenience. However, the modest size of this offering raises questions about the company's market position and growth strategy. Key considerations include:
- Market saturation in the wellness sector
- Competitive landscape and XWELL's unique value proposition
- Potential for expansion or new product development with capital infusion
The premium pricing suggests some investor belief in XWELL's potential, but the company needs to demonstrate how this small capital raise will translate into meaningful market share gains or product innovations to justify the premium and maintain investor interest.
NEW YORK, Aug. 08, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”), an authority in wellness solutions for people on the go, today announced the closing of its previously announced registered direct offering priced at a premium to market for the issuance and sale of an aggregate of 652,705 shares of its common stock, par value
The gross proceeds to the Company from the offering were approximately
The shares of common stock offered in the registered direct offering described above were offered by the Company pursuant to a shelf registration statement on Form S-3 (File No. 333-273726) that was previously filed with the Securities and Exchange Commission (“SEC”) on August 4, 2023, and subsequently declared effective on September 29, 2023. The offering of the shares of common stock issued in the registered direct offering was made only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement. A final prospectus supplement and accompanying base prospectus relating to, and describing the terms of, the registered direct offering has been filed with the SEC and is available on the SEC’s website at www.sec.gov.
This press release does not constitute an offer to sell or a solicitation of an offer to buy the securities in this offering, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.
About XWELL, Inc.
XWELL, Inc. (Nasdaq: XWEL) is a leading global wellness holding company operating multiple brands: XpresSpa®, Treat™, Naples Wax Center®, XpresCheck® and HyperPointe™.
- XpresSpa is a leading retailer of wellness services and related products, with 33 locations in 16 airports globally.
- Naples Wax Center is a group of upscale skin care boutiques, with three locations currently operating.
- XpresCheck is a provider of screening and diagnostic testing in partnership with the CDC and Concentric by Ginkgo, conducting biosurveillance monitoring in its airport locations to identify new SARS-CoV-2 variants of interest and concern as well as other pathogens entering the country from across the world.
- HyperPointe is a leading digital healthcare and data analytics relationship company serving the global healthcare industry.
Forward-looking Statements
This press release may contain “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These include statements preceded by, followed by or that otherwise include the words “believes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “should,” “seeks,” “future,” “continue,” or the negative of such terms, or other comparable terminology, and include such risks and uncertainties such as market and other conditions. Forward-looking statements relating to expectations about future results or events, including statements related to the intended use of proceeds the registered direct offering, the Company’s current plans and expectations relating to the business and operations and future store openings, including but not limited to, future openings of Naples Wax Center and XpresSpa stores, are based upon information available to XWELL as of the date of this press release, and are not guarantees of the future performance of the Company, and actual results may vary materially from the results and expectations discussed. Additional information concerning these and other risks is contained in the Company’s Annual Report on Form 10-K, as amended, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, and other SEC filings. All subsequent written and oral forward-looking statements concerning XWELL, or other matters and attributable to XWELL or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements above. XWELL does not undertake any obligation to publicly update any of these forward-looking statements to reflect events or circumstances that may arise after the date hereof.
FAQ
How much did XWELL (XWEL) raise in its recent registered direct offering?
At what price were XWEL shares sold in the August 2024 offering?
How many shares of XWEL stock were issued in the August 2024 offering?
What will XWELL (XWEL) use the proceeds from the August 2024 offering for?
